Key Opioid Study 'Of Zero Assistance,' Doctor Testifies

By Cara Salvatore (June 30, 2021, 6:44 PM EDT) -- Janssen began its defense Wednesday in a California trial against opioid manufacturers by calling to the stand an addiction psychiatrist who said a key plaintiffs' study on the likelihood of developing opioid addiction was "of zero assistance."

Janssen brought psychiatrist Dr. Douglas Tucker to testify about the proportions of the addiction crisis, which three California counties and one city allege Janssen, Teva Pharmaceuticals, Endo Pharmaceuticals Inc. and Johnson & Johnson helped cause.

Tucker criticized a key 2015 study from the journal Pain called the Vowles study, which surveyed 38 other studies and found that 21% to 29% of patients who are...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!